6-116877408-G-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_173560.4(RFX6):āc.133G>Cā(p.Val45Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,605,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173560.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RFX6 | NM_173560.4 | c.133G>C | p.Val45Leu | missense_variant | 1/19 | ENST00000332958.3 | |
RFX6 | XM_011535589.2 | c.133G>C | p.Val45Leu | missense_variant | 1/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RFX6 | ENST00000332958.3 | c.133G>C | p.Val45Leu | missense_variant | 1/19 | 1 | NM_173560.4 | P1 | |
RFX6 | ENST00000487683.5 | n.197G>C | non_coding_transcript_exon_variant | 1/14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000691 AC: 16AN: 231408Hom.: 0 AF XY: 0.0000557 AC XY: 7AN XY: 125608
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1453212Hom.: 0 Cov.: 32 AF XY: 0.0000111 AC XY: 8AN XY: 721948
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74336
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2022 | The c.133G>C (p.V45L) alteration is located in exon 1 (coding exon 1) of the RFX6 gene. This alteration results from a G to C substitution at nucleotide position 133, causing the valine (V) at amino acid position 45 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at